Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.28−0.01 (-3.78%)
Close on Nov 11, 2026Market cap $1.74MP/E –Yield –
Co-Diagnostics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Co-Diagnostics's profit margin for the twelve months ending Sep 30, 2026 was -5527.6%. For fiscal 2025 it was -7533.6%, against -961.4% the year before. The highest annual figure on record is 57.0% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7533.6% | −6572.3 |
| FY2024 | Dec 31, 2024 | -961.4% | −442.7 |
| FY2023 | Dec 31, 2023 | -518.7% | −477.1 |
| FY2022 | Dec 31, 2022 | -41.6% | −79.1 |
| FY2021 | Dec 31, 2021 | 37.5% | −19.5 |
| FY2020 | Dec 31, 2020 | 57.0% | +2939.0 |
| FY2019 | Dec 31, 2019 | -2882.0% | +12832.3 |
| FY2018 | Dec 31, 2018 | -15714.3% | +75113.6 |
| FY2017 | Dec 31, 2017 | -90827.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -2229.4% | +1819.9 |
| Q2 FY2026 | Jun 30, 2026 | -3782.4% | +962.6 |
| Q1 FY2026 | Mar 31, 2026 | -6262.3% | +8721.3 |
| Q4 FY2025 | Dec 31, 2025 | -9755.1% | −2367.7 |
| Q3 FY2025 | Sep 30, 2025 | -4049.3% | −2536.9 |
| Q2 FY2025 | Jun 30, 2025 | -4745.0% | −4459.0 |
| Q1 FY2025 | Mar 31, 2025 | -14983.5% | −12993.2 |
| Q4 FY2024 | Dec 31, 2024 | -7387.4% | −6974.6 |
| Q3 FY2024 | Sep 30, 2024 | -1512.4% | −1268.9 |
| Q2 FY2024 | Jun 30, 2024 | -286.0% | +4222.8 |
| Q1 FY2024 | Mar 31, 2024 | -1990.4% | −1034.3 |
| Q4 FY2023 | Dec 31, 2023 | -412.8% | +1150.2 |
| Q3 FY2023 | Sep 30, 2023 | -243.5% | −216.7 |
| Q2 FY2023 | Jun 30, 2023 | -4508.9% | −4455.4 |
| Q1 FY2023 | Mar 31, 2023 | -956.1% | −1007.7 |
| Q4 FY2022 | Dec 31, 2022 | -1563.0% | −1599.8 |
| Q3 FY2022 | Sep 30, 2022 | -26.7% | −64.8 |
| Q2 FY2022 | Jun 30, 2022 | -53.5% | −89.2 |
| Q1 FY2022 | Mar 31, 2022 | 51.6% | +12.2 |
| Q4 FY2021 | Dec 31, 2021 | 36.8% | −10.4 |
| Q3 FY2021 | Sep 30, 2021 | 38.1% | −34.0 |
| Q2 FY2021 | Jun 30, 2021 | 35.8% | −26.6 |
| Q1 FY2021 | Mar 31, 2021 | 39.4% | +108.2 |
| Q4 FY2020 | Dec 31, 2020 | 47.2% | +1645.3 |
| Q3 FY2020 | Sep 30, 2020 | 72.1% | +4290.3 |
| Q2 FY2020 | Jun 30, 2020 | 62.4% | +2245.8 |
| Q1 FY2020 | Mar 31, 2020 | -68.8% | +40177.9 |
| Q4 FY2019 | Dec 31, 2019 | -1598.1% | +16402.1 |
| Q3 FY2019 | Sep 30, 2019 | -4218.2% | +12707.8 |
| Q2 FY2019 | Jun 30, 2019 | -2183.4% | +11968.6 |
| Q1 FY2019 | Mar 31, 2019 | -40246.7% | −26733.6 |
| Q4 FY2018 | Dec 31, 2018 | -18000.3% | +39928.0 |
| Q3 FY2018 | Sep 30, 2018 | -16926.0% | +132939.6 |
| Q2 FY2018 | Jun 30, 2018 | -14152.0% | +20519.8 |
| Q1 FY2018 | Mar 31, 2018 | -13513.1% | – |
| Q4 FY2017 | Dec 31, 2017 | -57928.3% | – |
| Q3 FY2017 | Sep 30, 2017 | -149865.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -34671.8% | – |
See a number that looks wrong?